Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4449860
Max Phase: Preclinical
Molecular Formula: C14H11N3O2
Molecular Weight: 253.26
Molecule Type: Unknown
Associated Items:
ID: ALA4449860
Max Phase: Preclinical
Molecular Formula: C14H11N3O2
Molecular Weight: 253.26
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(Cn1nnc2ccccc21)c1ccccc1O
Standard InChI: InChI=1S/C14H11N3O2/c18-13-8-4-1-5-10(13)14(19)9-17-12-7-3-2-6-11(12)15-16-17/h1-8,18H,9H2
Standard InChI Key: NBWCVABTCXAVPE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 253.26 | Molecular Weight (Monoisotopic): 253.0851 | AlogP: 2.02 | #Rotatable Bonds: 3 |
Polar Surface Area: 68.01 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.06 | CX Basic pKa: 0.47 | CX LogP: 3.00 | CX LogD: 2.99 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.72 | Np Likeness Score: -1.62 |
1. Hameed S, Kanwal, Seraj F, Rafique R, Chigurupati S, Wadood A, Rehman AU, Venugopal V, Salar U, Taha M, Khan KM.. (2019) Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies., 183 [PMID:31514061] [10.1016/j.ejmech.2019.111677] |
Source(1):